New Delhi, May 29, 2015
India’s leading animal healthcare company, Hester Biosciences Limited has reported a strong growth in FY 2014-15 audited results.
Audited Financial Highlights | INR in Crores | ||
FY 15 | FY 14 | Growth | |
Net Sales | 90.04 | 69.04 | 30% |
Net Profit | 14.58 | 10.08 | 45% |
EPS in INR | 17.14 | 11.86 | 45% |
FY 14-15 Highlights
Dividend
In line with the dividend payout policy of the company, the Board of Directors has recommended a dividend of 31%, which is INR 3.10 per equity share, subject to approval from the shareholders.
Overall Performance
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…